ReShape Lifesciences Inc (RSLS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Dan W. Gladney
Employees:
50
1001 CALLE AMANECER, SAN CLEMENTE, CA 92673
9494296680

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using high frequency, low energy, electrical impulses. Its initial product Maestro System, which uses VBLOC therapy to affect metabolic regulatory control, limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN.

Data derived from most recent annual or quarterly report
Market Cap 52.613 Million Shares Outstanding10.022 Million Avg 30-day Volume 719
P/E Ratio0.0 Dividend Yield0.0 EPS-3.6
Price to Revenue2.7597 Debt to Equity1.0441 EBITDA-6.337 Million
Price to Book Value2.5478 Operating Margin-90.64020000000001 Enterprise Value43.697 Million
Current Ratio0.381 EPS Growth0.666 Quick Ratio0.197
1 Yr BETA 6.4998 52-week High/Low 0.0 / Profit Margin-189.1825
Operating Cash Flow Growth38.1406 Altman Z-Score-20.4149 Free Cash Flow to Firm -6.262 Million

Are you looking for this stock instead?

View SEC Filings from RSLS instead.

View recent insider trading info

ReShape Lifesciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RSLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RSLS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2021-06-22 by ARMISTICE CAPITAL, LLC
  • 4: filed on 2020-04-15 by ARMISTICE CAPITAL, LLC
  • 4: filed on 2020-03-27 by ARMISTICE CAPITAL, LLC
  • 4: filed on 2019-09-25 by Boyd Steven
  • 3: filed on 2019-06-24 by ARMISTICE CAPITAL, LLC
  • 3: filed on 2019-04-10 by BANDY BARTON P.
  • 3: filed on 2019-01-17 by SABBY MANAGEMENT, LLC
  • 3: filed on 2018-08-29 by MINOCHERHOMJEE ARDA PHD
  • 4: filed on 2018-06-05 by HealthCor Partners Fund II, L.P.
  • 3: filed on 2018-06-05 by HealthCor Partners Fund II, L.P.

    • Events (8k)

  • 8-K: filed on 2021-06-15:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-05-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-03-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-01-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-12-22:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-09-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-06-26:
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2020-03-31:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    STANKOVICH THOMAS CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2021-06-15 0

    ARMISTICE CAPITAL, LLC

    ARMISTICE CAPITAL MASTER FUND LTD.

    BOYD STEVEN

    • 10% Owner
    		 No longer subject to file 2021-06-15 0

    BANDY BARTON P. PRESIDENT AND CEO

    • Officer
    		 0 2019-04-01 0

    SABBY MANAGEMENT, LLC

    • 10% Owner
    		 1,043,408 2019-01-15 0

    MINOCHERHOMJEE ARDA PHD

    • Director
    		 0 2018-08-13 0

    GLADNEY DAN W CHAIRMAN, PRESIDENT AND CEO

    • Officer
    • Director
    		 1,925 2018-04-18 0

    YOUNGSTROM SCOTT P CFO AND SVP, FINANCE

    • Officer
    		 0 2018-04-18 0

    HEALTHCOR PARTNERS FUND II, L.P.

    HEALTHCOR PARTNERS MANAGEMENT LP

    HEALTHCOR PARTNERS MANAGEMENT GP, LLC

    HEALTHCOR PARTNERS II, L.P.

    HEALTHCOR PARTNERS GP, LLC

    COHEN ARTHUR BRUCE

    HEALEY JOSEPH PATRICK

    LIGHTCAP JEFFREY C

    • 10% Owner
    		 174,472 2017-12-19 0

    MASHAAL MICHAEL Y

    • Director
    		 2,643,277 2017-12-19 0

    HAGGERTY ROBERT C. VP, U.S. COMMERCIAL SALES

    • Officer
    		 0 2017-11-08 0

    SCOTT AMY L. VP, MARKETING & PATIENT ACCESS

    • Officer
    		 0 2017-11-08 0

    SCHMALZ DEBORAH L. VP, CLINICAL, REG AFF. & QUAL.

    • Officer
    		 1,000 2017-11-08 0

    ANSARI NAQEEB A. VP, INT'L SALES & US VET HOSP.

    • Officer
    		 No longer subject to file 2017-10-06 0

    GOLDFISCHER CARL

    • Director
    		 0 2017-05-25 0

    NIHALANI RAJESH CHIEF TECHNOLOGY OFFICER

    • Officer
    		 0 2017-05-22 0

    BLACKFORD GARY

    • Director
    		 0 2017-02-08 0

    TETI NICHOLAS

    • Director
    		 10 2017-02-08 0

    GRIFFIN BOBBY IVAN

    • Director
    		 52 2017-02-08 0

    TREMMEL JON T

    • Director
    		 2 2017-02-08 0

    MCDOUGAL LORI COURTNEY

    • Director
    		 0 2017-02-08 0

    DELANGE PETER M. SVP, OPS & BUS DEV

    • Officer
    		 393 2017-02-08 0

    HICKEY PAUL F. SVP OF MKTG & REIMB

    • Officer
    		 0 2017-02-08 0

    LEA GREGORY S CFO AND CCO

    • Officer
    		 184 2016-06-27 0

    SHIKORA SCOTT A EVP & CHIEF MEDICAL OFFICER

    • Officer
    		 0 2016-06-27 0

    KNUDSON MARK B

    • Director
    		 45,013 2016-05-04 0

    JANSZ ANTHONY P.

    • Director
    		 11,667 2016-05-04 0

    FRIEDMAN CATHY

    • Director
    		 13,800 2015-05-06 0

    HANCOCK BRADFORD C CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2015-05-06 0

    DONDERS ADRIANUS SR VP OF RESEARCH & ADV DEV

    • Officer
    		 0 2015-03-09 0

    TWEDEN KATHERINE S. VP - CLINICAL AND REGULATORY

    • Officer
    		 1,053 2015-03-09 0

    EVNIN LUKE

    • Director
    		 0 2014-05-07 0

    KLINGENSTEIN PAUL H

    • Director
    		 0 2013-05-08 0

    DOUGLAS KEVIN

    DOUGLAS MICHELLE

    DOUGLAS FAMILY TRUST

    JAMES & JEAN DOUGLAS IRREVOCABLE DESCENDANTS TRUST

    KGD 2010 ANNUITY TRUST VI

    MMD 2010 ANNUITY TRUST VI

    • 10% Owner
    • 13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP
    		 10,951,705 2013-02-22 0

    WHITEBOX ADVISORS LLC

    WHITEBOX MULTI-STRATEGY PARTNERS LP

    WHITEBOX L/S EQUITY PARTNERS LP

    PANDORA SELECT PARTNERS, L.P.

    HFR MASTER TRUSTS

    • 10% Owner
    • SEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOW
    		 2,455,462 2012-09-23 0

    WHITEBOX ADVISORS LLC

    WHITEBOX MULTI-STRATEGY PARTNERS LP

    WHITEBOX SMALL CAP LONG SHORT EQUITY PARTNERS LP

    PANDORA SELECT PARTNERS, L.P.

    HFR MASTER TRUSTS

    KOHLER GARY S

    • 10% Owner
    • SEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOW
    		 6,945,806 2011-09-23 0

    BAY CITY CAPITAL LLC

    BAY CITY CAPITAL FUND IV, L.P.

    BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

    BAY CITY CAPITAL MANAGEMENT IV LLC

    • 10% Owner
    		 8,545,079 2011-09-23 0

    WHITEBOX ADVISORS LLC

    WHITEBOX MULTI-STRATEGY PARTNERS LP

    WHITEBOX SMALL CAP LONG SHORT EQUITY ADVISORS, LLC

    PANDORA SELECT PARTNERS, L.P.

    HFR MASTER TRUSTS

    • 10% Owner
    • SEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOW
    		 1,932,600 2011-03-07 0

    MARXE AUSTIN W & GREENHOUSE DAVID M

    • 10% Owner
    		 No longer subject to file 2011-02-08 0

    HARRISON DONALD C

    • Director
    		 340,215 2010-12-14 0

    GADICKE ANSBERT

    GALAKATOS NICHOLAS

    HENNER DENNIS

    STEINMETZ MICHAEL

    SIMON NICHOLAS J III

    WHEELER KURT

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2010-12-14 0

    MPM BIOVENTURES III-QP L.P.

    MPM BIOVENTURES III PARALLEL FUND, L.P.

    MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

    MPM BIOVENTURES III L.P.

    MPM BIOVENTURES III GP L.P.

    MPM BIOVENTURES III LLC

    MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2010-12-14 0

    ABERDARE II ANNEX FUND L P

    ABERDARE GP II, L.L.C.

    ABERDARE VENTURES II, L.P.

    ABERDARE VENTURES II (BERMUDA), L.P.

    • FORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDERFORMER 10% STOCKHOLDER
    		 No longer subject to file 2010-12-14 0

    ABERDARE II ANNEX FUND L P

    ABERDARE GP II, L.L.C.

    • 10% Owner
    		 0 2010-09-30 0

    HUDSON BAY CAPITAL MANAGEMENT, L.P.

    HUDSON BAY FUND LP

    HUDSON BAY OVERSEAS FUND LTD.

    GERBER SANDER

    • 10% Owner
    		 6,161,068 2009-10-02 0

    KOSKINAS ELLEN E

    • Director
    		 2,564,364 2009-02-24 0

    ABERDARE VENTURES II, L.P.

    ABERDARE II ANNEX FUND L P

    ABERDARE GP II, L.L.C.

    • 10% Owner
    		 1,914,742 2008-05-29 0

    INTERWEST PARTNERS IX, LP

    CASH HARVEY B

    GIANOS PHILIP T

    HOLMES W STEPHEN

    KLIMAN GILBERT H

    ORONSKY ARNOLD L

    ROSCH THOMAS L

    SWEENEY MICHAEL B

    BOICH MICHAEL D

    CLEVELAND BRUCE A

    • 10% Owner
    		 1,546,761 2007-11-20 0

    INTERWEST MANAGEMENT PARTNERS IX, LLC

    EHRLICH CHRISTOPHER B

    GRAIS LINDA S

    KJELLSON NINA S

    NASH H RONALD

    NASR KHALED

    PEPPER DOUGLAS A

    WESTERLIND VICTOR A

    • 10% Owner
    		 1,546,761 2007-11-20 0

    FELKEY RUSS SR VP-CLINICAL,QUAL&REGAFFAIR

    • Officer
    		 17,353 2007-11-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 22:15:04 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 21:45:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 21:15:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 20:45:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 20:15:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 19:45:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 19:15:04 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 18:45:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 18:15:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 17:45:03 UTC -65.0946 65.1646 450000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 17:15:03 UTC -65.0946 65.1646 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 16:45:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 16:15:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 15:45:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 15:15:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 14:45:02 UTC -65.204 65.274 600000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 14:15:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 13:45:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 13:15:03 UTC -65.204 65.274 550000
    RESHAPE LIFESCIENCES INC RSLS 2021-10-15 12:45:03 UTC -65.204 65.274 500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments